Skip to search boxSkip to navigationSkip to main content

The Nonpsychoactive Cannabis Constituent Cannabidiol Is a Wake-Inducing Agent

  • Universidad Autónoma de Campeche
    ,
  • Universidad Nacional Autónoma de México
    ,
  • Hebrew University of Jerusalem
Research Output: Contribution to journal Article Peer-review

Publication Information

Output type

Research Output: Contribution to journal Article Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 1378-1382 (5 pages)

Journal (Volume, Issue Number)

Behavioral Neuroscience (Volume 122, Issue 6)

Publication milestones

  • Published - 01/12/2008

Publication status

Published - 01/12/2008

ISSN

0735-7044

Publication IDs

  • Scopus: 57049154057
  • PubMed: 19045957

Abstract

Cannabidiol (CBD) is a constituent of Cannabis sativa that induces nonpsychotropic effects, and some of its biological actions in sleep have been described by the authors' group. Here, the authors report that when administered 10 or 20 μg/1 μl during the lights-on period directly into either lateral hypothalamus (LH) or dorsal raphe nuclei (DRN), which are wake-inducing brain areas, CBD enhanced wakefulness and decreased slow wave sleep and REM sleep. Furthermore, CBD increased alpha and theta power spectra but diminished delta power spectra. Additionally, CBD increased c-Fos expression in LH or DRN. These findings suggest that this cannabinoid is a wake-inducing compound that presumably activates neurons in LH and DRN.

Publication metrics

Metrics

SciVal
FWCI
0.28

PlumX, opens in new tab

46
Mentions
10
Captures
101